학술논문

Virological Outcomes After Switching to Abacavir/Lamivudine/Dolutegravir Combined with Adherence Support in People Living with HIV with Poor Adherence: A Phase IV, Multicentre Randomized Prospective Open Label Study (TriiADD-CTN 286)
Document Type
Article
Source
In: Patient Preference and Adherence. (Patient Preference and Adherence, 2022, 16:3267-3281)
Subject
Language
English
ISSN
1177889X